HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min-Hsiung Pan Selected Research

garcinol

1/2021Inhibitory Effect of Garcinol on Obesity-Exacerbated, Colitis-Mediated Colon Carcinogenesis.
1/2019Garcinol Reduces Obesity in High-Fat-Diet-Fed Mice by Modulating Gut Microbiota Composition.
3/2017Garcinol sensitizes breast cancer cells to Taxol through the suppression of caspase-3/iPLA2 and NF-κB/Twist1 signaling pathways in a mouse 4T1 breast tumor model.
10/2015Antitumor Activity of Garcinol in Human Prostate Cancer Cells and Xenograft Mice.
11/2014Protective effects of garcinol on dimethylnitrosamine-induced liver fibrosis in rats.
9/2014Garcinol suppresses inflammation-associated colon carcinogenesis in mice.
1/2011Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
12/2010Garcinol inhibits cell growth in hepatocellular carcinoma Hep3B cells through induction of ROS-dependent apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min-Hsiung Pan Research Topics

Disease

77Neoplasms (Cancer)
01/2022 - 10/2004
46Inflammation (Inflammations)
01/2022 - 11/2006
36Carcinogenesis
09/2021 - 11/2006
25Obesity
03/2022 - 02/2012
12Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2002
12Breast Neoplasms (Breast Cancer)
01/2021 - 06/2007
12Leukemia
11/2011 - 10/2004
11Body Weight (Weight, Body)
01/2022 - 07/2013
11Neoplasm Metastasis (Metastasis)
01/2021 - 07/2009
10Colonic Neoplasms (Colon Cancer)
01/2022 - 11/2009
10Liver Cirrhosis (Hepatic Cirrhosis)
11/2021 - 02/2013
8Papilloma (Papillomatosis)
02/2014 - 11/2006
7Fibrosis (Cirrhosis)
11/2021 - 06/2013
7Colitis
06/2021 - 04/2012
6Non-alcoholic Fatty Liver Disease
09/2020 - 01/2014
5Colitis-Associated Neoplasms
01/2021 - 09/2014
5Aberrant Crypt Foci
05/2017 - 08/2010
5Hepatocellular Carcinoma (Hepatoma)
05/2013 - 07/2009
5Carcinoma (Carcinomatosis)
01/2011 - 02/2005
4Adenocarcinoma
11/2021 - 02/2011
4Insulin Resistance
09/2020 - 01/2014
4Cardiovascular Diseases (Cardiovascular Disease)
10/2019 - 01/2013
3Triple Negative Breast Neoplasms
01/2021 - 11/2011
3Hyperlipidemias (Hyperlipidemia)
12/2020 - 01/2013
3Atherosclerosis
10/2019 - 02/2010
3Necrosis
10/2019 - 06/2015
2Weight Gain
03/2022 - 10/2015
2Liver Diseases (Liver Disease)
09/2021 - 09/2020

Drug/Important Bio-Agent (IBA)

24pterostilbeneIBA
01/2022 - 09/2007
20Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2008
16ResveratrolIBA
11/2021 - 03/2008
14CaspasesIBA
04/2011 - 07/2003
13TeaIBA
03/2022 - 06/2007
12LipidsIBA
03/2022 - 02/2012
11AzoxymethaneIBA
01/2021 - 08/2010
11Reactive Oxygen Species (Oxygen Radicals)IBA
03/2011 - 02/2005
10anthraceneIBA
01/2021 - 11/2006
9Messenger RNA (mRNA)IBA
01/2022 - 01/2010
8StilbenesIBA
11/2021 - 03/2008
8CurcuminIBA
08/2021 - 09/2010
8garcinolIBA
01/2021 - 12/2010
8PhytochemicalsIBA
01/2021 - 06/2012
7Dextran SulfateIBA
09/2021 - 04/2012
7EnzymesIBA
09/2021 - 11/2008
7Biological ProductsIBA
01/2020 - 04/2012
7PolyphenolsIBA
12/2019 - 06/2007
6Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2014
6CytokinesIBA
09/2021 - 10/2010
5Carbon Tetrachloride (Tetrachloromethane)IBA
11/2021 - 09/2017
5Insulin (Novolin)FDA Link
01/2021 - 01/2014
5Dextrans (Dextran)FDA Link
01/2021 - 01/2017
5sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2021 - 01/2017
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2021 - 06/2007
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 02/2011
5Antineoplastic Agents (Antineoplastics)IBA
08/2016 - 12/2007
5AntioxidantsIBA
01/2013 - 07/2009
55- hydroxy- 3,6,7,8,3',4'- hexamethoxyflavoneIBA
10/2011 - 06/2007
43,3',4,5'-tetrahydroxystilbeneIBA
01/2022 - 10/2016
4CollagenIBA
09/2021 - 01/2012
4CarcinogensIBA
09/2021 - 05/2017
43'-hydroxypterostilbeneIBA
01/2021 - 01/2014
4CholesterolIBA
12/2020 - 04/2016
4Therapeutic UsesIBA
01/2020 - 03/2008
4tetrahydrocurcuminIBA
01/2020 - 11/2011
4FlavonoidsIBA
07/2019 - 03/2013
4Dronabinol (THC)FDA LinkGeneric
12/2018 - 11/2011
4Cyclin D1IBA
05/2017 - 02/2011
4NicotineFDA Link
04/2016 - 01/2010
4Dimethylnitrosamine (Nitrosodimethylamine)IBA
06/2015 - 02/2013
4ErbB Receptors (EGF Receptor)IBA
11/2012 - 06/2007
4shogaolIBA
09/2010 - 05/2008
4Cytochromes c (Cytochrome c)IBA
11/2007 - 07/2003
3Blood Glucose (Blood Sugar)IBA
01/2022 - 09/2018
3Polysaccharides (Glycans)IBA
01/2022 - 08/2010
3XenobioticsIBA
09/2021 - 01/2018
3Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2021 - 03/2008
3Ethanol (Ethyl Alcohol)IBA
09/2020 - 05/2013
3Carnitine (L-Carnitine)FDA LinkGeneric
09/2020 - 07/2019
3trimethyloxamine (trimethylamine N-oxide)IBA
10/2019 - 06/2019
3nobiletinIBA
06/2019 - 02/2010
3Transaminases (Aminotransferases)IBA
02/2018 - 11/2014
3Hormones (Hormone)IBA
01/2018 - 03/2011
3CateninsIBA
05/2017 - 02/2011
3Transcription Factors (Transcription Factor)IBA
11/2016 - 02/2011
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2013 - 02/2011
3NF-kappa B (NF-kB)IBA
01/2012 - 11/2006
3Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2011 - 01/2010
3gingerolIBA
09/2010 - 05/2008
3Glutathione (Reduced Glutathione)IBA
03/2010 - 08/2006
2Benzo(a)pyreneIBA
09/2021 - 01/2018
25-demethylnobiletinIBA
09/2021 - 05/2011
2Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
01/2021 - 03/2013
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2011
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2018
2Acetates (Acetic Acid Esters)FDA Link
01/2021 - 11/2012
2TransferasesIBA
09/2020 - 02/2018

Therapy/Procedure

14Chemoprevention
11/2020 - 06/2007
7Therapeutics
01/2022 - 12/2010
4Drug Therapy (Chemotherapy)
11/2020 - 03/2008
4Oral Administration
04/2020 - 06/2013